Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A Unicorn
Yale Spinout Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
Prepared (co-founded by Michael Chime YC ’21, Dylan Gleicher YC ’21, and Neal Soni YC ’22) closes a $16 Million round
Yale spinout Allyx Therapeutics to Present Phase 1 Data for Lead Compound ALX-001 at the 16th Clinical Trials on Alzheimer's Disease Meeting
Yale Spinout, Cybrexa Therapeutics, to Debut Preclinical Data Demonstrating CBX-15 is Safe and Highly Efficacious in 13762 Triple Negative Breast Cancer Model
Guideli, founded by Harvard and Yale MBA students, plans to help immigrants settle down in their new countries
Yale Start-up Tetricus Gets Seed Investment to Commercialize Machine Learning Platform for Mental Illness Diagnosis and Treatment